Quantcast
Home > Quotes > BHC

Bausch Health Companies Inc. Common Stock (BHC) Quote & Summary Data

BHC 
$25.6875
*  
0.0175
0.07%
Get BHC Alerts
*Delayed - data as of Nov. 16, 2018 10:44 ET  -  Find a broker to begin trading BHC now
Exchange:NYSE
Industry: Health Care
Community Rating:
View:    BHC Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

1 Year Target
29.5
Today's High / Low
$ 26.025 / $ 25.36
Share Volume
759,024
90 Day Avg. Daily Volume
4,802,501
Previous Close
$ 25.67
52 Week High / Low
$ 28.45 / $ 14.22
Market Cap
8,984,389,436
P/E Ratio
NE
Forward P/E (1y)
6.86
Earnings Per Share (EPS)
$ -9.72
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
1.48 %
Beta
0

Intraday Chart

Shares Traded

Share Volume:
759,024
90 Day Avg. Daily Volume:
4,802,501

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
6.86
Earnings Per Share (EPS):
$ -9.72

Trading Range

The current last sale of $25.6875 is 80.64% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 26.025 $ 28.45
 Low: $ 25.36 $ 14.22

ETFs with BHC as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
4.98% VanEck Vectors Pharmaceutical ETF (PPH) +2.57 (4.32%)
3.33% Invesco Dynamic Pharmaceuticals ETF (PJP) +1.07 (1.59%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

Biovail Corporation ("Biovail") was formed under the Business Corporations Act (Ontario) on February 18, 2000, as a result of the amalgamation of TXM Corporation and Biovail Corporation International. Biovail was continued under the Canada Business Corporations Act (the "CBCA") effective June 29, 2005. In connection with the acquisition of Valeant Pharmaceuticals International ("Valeant") in September 2010, Biovail was renamed "Valeant Pharmaceuticals International, Inc." Effective August 9, 2013, we continued from the federal jurisdiction of Canada to the Province of British Columbia, meaning that we became a company registered under the laws of the Province of British Columbia as if we had been incorporated under the laws of the Province of British Columbia.  ... More ...  


Risk Grade

Where does BHC fit in the risk graph?


Risk Grade Scale

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x